Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3 vs 6 Months Initial Steroid Treatment in Children with SSNS
NCT04536181Phase 3Withdrawn
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jan 2021
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisolone in nephrotic syndrome (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Occurrence of frequent relapses of nephrotic syndrome. Planned start Jan 2021; status: withdrawn.
02
Drugs
prednisolone
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT04536181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536181.